AU562517B2 - Biostimulating agent containing creatine - Google Patents

Biostimulating agent containing creatine

Info

Publication number
AU562517B2
AU562517B2 AU15432/83A AU1543283A AU562517B2 AU 562517 B2 AU562517 B2 AU 562517B2 AU 15432/83 A AU15432/83 A AU 15432/83A AU 1543283 A AU1543283 A AU 1543283A AU 562517 B2 AU562517 B2 AU 562517B2
Authority
AU
Australia
Prior art keywords
hydrolyzate
weight
agent containing
creatine
containing creatine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU15432/83A
Other versions
AU1543283A (en
Inventor
Pencho Varbanov Burov
Mihail Stefanov Kirov
Ivan Hristov Kovachev
Ivan Hristov Radoslovov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmachim DSO
Original Assignee
Pharmachim DSO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmachim DSO filed Critical Pharmachim DSO
Publication of AU1543283A publication Critical patent/AU1543283A/en
Application granted granted Critical
Publication of AU562517B2 publication Critical patent/AU562517B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Abstract

1. A biostimulant comprising creatine and the hydrolyzate of protein, characterized in that as the hydrolyzate of protein there is contained lyophylized hydrolyzate of Royal Jelly and that the biostimulant furthermore contains calcium-magnesium salt of inositephosphoric acid and galanthamine-hydrobromide, whereby the ratio of the individual components is the following : 40 to 45% by weight of creatine ; 42 to 46% by weight of calcium-magnesium salt of inositephosphoric acid ; 10 to 12% by weight of lyophylized hydrolyzate of Royal Jelly ; 1 to 3% by weight of galanthamine-hydrobromide.
AU15432/83A 1982-06-09 1983-06-07 Biostimulating agent containing creatine Ceased AU562517B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE32218273 1982-06-09
DE19823221827 DE3221827A1 (en) 1982-06-09 1982-06-09 BIOSTIMULATING AGENT

Publications (2)

Publication Number Publication Date
AU1543283A AU1543283A (en) 1983-12-15
AU562517B2 true AU562517B2 (en) 1987-06-11

Family

ID=6165747

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15432/83A Ceased AU562517B2 (en) 1982-06-09 1983-06-07 Biostimulating agent containing creatine

Country Status (7)

Country Link
EP (1) EP0098975B1 (en)
JP (1) JPS5962528A (en)
AT (1) ATE15604T1 (en)
AU (1) AU562517B2 (en)
DE (1) DE3221827A1 (en)
GR (1) GR77543B (en)
NO (1) NO832057L (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5312817A (en) * 1991-05-14 1994-05-17 Ernir Snorrason Treatment of fatigue syndrome
CH688760A5 (en) * 1995-04-28 1998-03-13 Synergen Ag A topical preparation for promotion of muscle growth.
DE19537494C2 (en) * 1995-09-25 1997-10-02 Desitin Arzneimittel Gmbh Creatine to protect neural tissue
WO1998000148A1 (en) * 1996-06-28 1998-01-08 Ipr-Institute For Pharmaceutical Research Ag Drug preparations, containing creatine with at least one salt of calcium, magnesium, manganese or zinc
US8603546B2 (en) 1999-01-11 2013-12-10 Herbaceuticals Inc. Herbal supplement for increased muscle strength and endurance for athletes
US6159476A (en) * 1999-01-11 2000-12-12 Herbaceuticals Herbal supplement for increased muscle strength and endurance for athletes
AU2001253598B9 (en) * 2000-04-19 2006-02-23 Advantrx Corporation A combination of pinitol and creatine to enhance uptake and retention of creatine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2254777A (en) * 1936-08-26 1941-09-02 Walther H Duisberg Process of producing artificial staple fibers resembling wool
GB1012121A (en) * 1961-03-13 1965-12-08 Yamanouchi Pharma Co Ltd A method of preparing a pharmacologically active protein material from royal bee jelly
FR1326611A (en) * 1962-04-05 1963-05-10 Process for activating royal bee jelly, products for carrying out the process and products according to those obtained by the present process or similar process

Also Published As

Publication number Publication date
EP0098975B1 (en) 1985-09-18
JPS5962528A (en) 1984-04-10
NO832057L (en) 1983-12-12
AU1543283A (en) 1983-12-15
GR77543B (en) 1984-09-24
DE3221827A1 (en) 1983-12-15
ATE15604T1 (en) 1985-10-15
EP0098975A1 (en) 1984-01-25

Similar Documents

Publication Publication Date Title
PH21250A (en) Sucralfate supsension
PH24867A (en) A method of treating conditions associated with photodamaged skin by using pharmaceutical compositions containing p(22-(5,6,7,8 tetrahydro-5,5,8,8-tetramethyl-2-naphtyl)propenyl)phenylsulfone and derivatives thereof
DK581185A (en) PHARMACEUTICAL PREPARATION CONTAINING 13-CIS-A-VITAMIC ACID
AU566955B2 (en) Antidiarrheal compositions containing bismuth subsalicylate
AU553789B2 (en) Glycyrrhetinic acid derivatives in cream compositions
AU578031B2 (en) Lithium salt antiviral compositions
AU562517B2 (en) Biostimulating agent containing creatine
AU5425886A (en) Anticalculus oral composition containing phosphonoformic acid
GR3005282T3 (en)
HUT46530A (en) Kosmetical composition containing 13-cis-retinic acid
AU550658B2 (en) Dialkyl sulphosuccinates detergents with added magnesium ions
AU569176B2 (en) Preparation of 2,4-dichloro-5-fluoro-benzoic acid
JPS5648857A (en) Low-protein feed
EP0199257A3 (en) L-aminodicarboxylic acid esters and an edible composition containing same as sweeteners
ES8501380A1 (en) Zinc salt of L-thiazolidine-4-carboxylic acid, its preparation, compositions containing it and its use.
JPS57171908A (en) Agent for preventing falling-out of hair, promoting growth and occurrence of hair
DE3162067D1 (en) Plant-growth regulating compositions containing as active agent 2-methylene-succinamic acid derivatives, and derivatives of this acid useful in these compositions
AU557798B2 (en) Radiographic imaging composition
JPS57100177A (en) Mixed agent composition of amino acid with saccharide
EP0364928A3 (en) Paste-like dentifrice composition
AU563760B2 (en) Etofenamate formulations
SU718502A1 (en) Zinc-nickel alloy electrolyte
GB2165153B (en) Hydrosoluble pharmaceutical compositions containing salts of (-)cis-1,2-epoxypropylphosphonic acid with aminoacids
AU1145283A (en) Preparation of 3,3:-diaminodiphenyl sulfones
JPS57177656A (en) Honey containing chlorella